MEMBERS TESTIMONIALS

Radiobotics

Neurescue

 Why did you decide to join the MedTech Bridge programme?

Because in order to define the future of our business we need to get qualified input on our strategic considerations. We believe MTB holds that expertise. Finally, it's a huge privilege that this is supported by the Danish government and we mostly only have to invest our time. 

 

What were your initial expectations and/or objective when joining the programme? 

To be honest, when we joined back then we had so much to learn about the American market and our only expectation was to know much more, which I strongly believe is the case. 

What was your overall experience from going to Minneapolis with MTB?

 Again it's a huge privilege to be able to receive this kind of support, and it just ensures that everyone spends their time on highly relevant things. Having Amy planning everything and ensure all meetings we relevant on held in a very professional manner is crucial for the overall success. 

 

How has your experience with MedTech Bridge prepared you for the future?

We will for sure return soon to leverage on the already established contacts and learnings, we don't have a fully fetched plan yet, but we're working in the right the direction. 

Stine Mølgaard, COO & Co-Founder

 

Why did you decide to join the MedTechBridge programme?

The MedtechBridge is an exciting opportunity for a start-up company like Neurescue - to increase our collaboration with clinical, commercial and financial partners in the US market. Especially now that we have our first fully developed product. The support of the MedTech Bridge program and its focus on the Minneapolis area is a great fit for us.

What were your initial expectations and/or objective when joining the programme?

Neurescue joined the MedTech Bridge looking for support during our entry to the US market, specifically regarding market access and to connect with relevant US clinical sites. These expectations have to date been fully realized with the support that we have been provided with.

 

What was your overall experience from going to Minneapolis with MTB?

On our visit to Minneapolis, we expected to meet with Minneapolis based stakeholders within clinical research, investments and the medical device ecosystem. We had many good take-aways from our visit, the top takeaway being that Minneapolis is a very relevant candidate for Neurescue’s US base of operations, given the presence of leading potential clinical sites, leading KOLs, and prominent potential exit partners.

 

How has your experience with MedTech Bridge prepared you for the future?


We have learned to reach out to new strategic partners earlier, as introduced through the MedTech Bridge network. We are also appreciating Minneapolis as ‘the’ home for innovative cardiovascular device companies.

 

Bjørn Broby Glavind, Business Development Director

© 2020 by MedTech Bridge

  • Twitter Social Ikon
  • LinkedIn Social Ikon

Proudly created with wix.com